Tong Ren Tang Technologies Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tong Ren Tang Technologies Company Limited with three other
companies in this sector in China:
Zhangzhou Pientzehuang Pharmaceutical Ltd
sales of 4.77 billion Chinese Renmimbi [US$676.03 million]
of which 49%
was Pharmaceutical Business),
Shijiazhuang Yiling Pharmaceutical Co Ltd
(4.81 billion Chinese Renmimbi [US$682.89 million]
of which 58%
was Blood vessel), and
Zhejiang Huahai Pharmaceutical
(5.09 billion Chinese Renmimbi [US$722.62 million]
of which 57%
was Drug Sale).
Tong Ren Tang Technologies Company Limited reported sales of 5.06 billion Chinese Renmimbi (US$717.66 million)
December of 2018.
a very small
increase of 0.7%
versus 2017, when the company's sales were 5.03 billion Chinese Renmimbi.
Sales at Tong Ren Tang Technologies Company Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 74%).
Sales of Tong Ren Tang Chinese Medicine saw an increase
that was more than double the company's growth rate: sales were up
17.0% in 2018, from
1.10 billion Chinese Renmimbi to 1.28 billion Chinese Renmimbi.
Tong Ren Tang Technologies Company Limited also saw significant increases in sales in
All Other Segments (up 7.4% to 1.05 billion Chinese Renmimbi)
Not all segments of Tong Ren Tang Technologies Company Limited experienced an increase in sales in 2018:
sales of the Company fell 8.2% to 3.22 billion Chinese Renmimbi.